Keynote: THE CI DELUSION: Why Everything You’ve Been Told About Biopharma Intelligence Is Wrong
Every team says the same thing:
“We’re covered.”
They point to dashboards.
Vendor decks.
AI-generated summaries.
And then the market moves—without them.
This isn’t about capacity.
It’s about credibility.
And the silent collapse of what CI was supposed to be.
Molekule Consulting, issues a direct challenge to the intelligence status quo:
Biopharma CI is not just delayed.
It’s miscalibrated.
It’s measuring the wrong signals, asking the wrong questions, trusting the wrong voices.
Yes, it is uncomfortable to hear this from a consultant.
The real discomfort is that it already feels true.
This keynote is not a presentation.
It is a classified debrief on the failure points your team won’t see—until it’s too late:
• How “coverage” became the enemy of consequence
• How AI fluency produces coherence without truth
• How HUMINT grids now shape strategy before advisory boards convene
• Why velocity has replaced vigilance—and no one noticed
After this session, you will not look at CI the same way.
If you do, that’s the most dangerous signal of all.
Presented by Molekule Consulting